pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
simvastatin
Simvastatin (simvastatin)
Cardiovascular Risk Factors
Yiling Pharmaceutical Ltd
1 catalysts
Marketed
sodium thiosulfate
Pedmark (sodium thiosulfate)
Hearing Disorders
$REGNREGENERON PHARMACEUTICALS, INC.
1 catalysts
Phase 2
soficabtagene geleucel
soficabtagene geleucel [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Wugen Inc
1 catalysts
← prev
page 7 of 231
next →
131
Pain89
Neurology1
Phase 3
soquelitinib
Peripheral T-Cell Lymphomas (PTCL)
$CRVSCorvus Pharmaceuticals, Inc.
1 catalysts
sugammadex
First Affiliated Hospital of Kunming Medical University
1 catalysts
pre_registration
tegoprazan
tegoprazan [INN]
Corrosive Esophagitis (Erosive Esophagitis)
Sebela Pharmaceuticals Inc
1 catalysts
Marketed
telavancin hydrochloride
Vibativ (telavancin hydrochloride)
Hospital Acquired Pneumonia (HAP)
$CPIXCUMBERLAND PHARMACEUTICALS INC
1 catalysts
Phase 3
telitacicept
telitacicept [INN]
Primary Sjogren's Syndrome
$VORVor Biopharma Inc.
1 catalysts
Phase 2
toripalimab
Loqtorzi (toripalimab-tpzi)
Esophageal Squamous Cell Carcinoma (ESCC)
Programmed cell death protein 1
$CHRSCoherus Oncology, Inc.
1 catalysts
Phase 3
tozorakimab
Acute Respiratory Failure
$AZNASTRAZENECA PLC
1 catalysts
Phase 3
tremelimumab
Imjudo (tremelimumab-actl)
Small-Cell Lung Cancer
Cytotoxic T-lymphocyte protein 4
$AZNASTRAZENECA PLC
1 catalysts
Phase 2
tulisokibart
Systemic Sclerosis (Scleroderma)
$MRKMerck & Co., Inc.
1 catalysts
tuvusertib
National Cancer Institute US
1 catalysts
Phase 2
ubidecarenone
ubidecarenone [INN]
Metastatic Adenocarcinoma of The Pancreas
BPGbio Inc
1 catalysts
umbilical cord mesenchymal stem cells derived apoptotic vesicles
Shenzhen Eye Hospital
1 catalysts
undisclosed Covid-19 vaccine
Barts Charity
1 catalysts
undisclosed anesthetic drug
Beijing Jishuitan Hospital
1 catalysts
undisclosed anti-diuretics
The National Institute of Diabetes and Digestive and Kidney Diseases
1 catalysts
undisclosed immunosuppressive drug
KLE College of Pharmacy, Belagavi
1 catalysts
undisclosed mineral supplement
Athletic Greens International Inc
1 catalysts
undisclosed plant extract
KSO Corp
1 catalysts
undisclosed sodium glucose cotransporter 2 inhibitor
National Key Research and Development Program
1 catalysts
undisclosed traditional Chinese medicine
Dongguan Traditional Chinese Medicine Hospital
1 catalysts
ursodeoxycholic acid
Sheikh Zayed Medical College Rahim Yar Khan
1 catalysts
vardenafil
LTR Pharma Ltd
1 catalysts
Marketed
verteporfin
Visudyne (verteporfin)
Age Related Macular Degeneration
Bausch Health US LLC
1 catalysts
yingtao shujie paste
Second Affiliated Hospital of Anhui Medical University
1 catalysts
zigakibart
$NVSNOVARTIS AG
1 catalysts
Marketed
goserelin LA
Zoladex (goserelin)
Metrorrhagia (Abnormal Uterine Bleeding)
TerSera Therapeutics LLC
76 catalysts
Marketed
(daratumumab + hyaluronidase (human recombinant))
Darzalex Faspro ((daratumumab + hyaluronidase (human recombinant)-fihj))
Multiple Myeloma (Kahler Disease)
Janssen Biotech Inc
16 catalysts